RECRUITING

Device Use Reimagined Through Education And Mentorship

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Diabetes technology, such as insulin pumps and continuous glucose monitoring devices, can help improve glucose control for people with type 1 diabetes (T1D), which keeps them at lower risk for diabetes complications, but many Latinx adolescents, who make up the largest marginalized ethnic group of youth with T1D in California, use these devices less often and have less optimal glucose control compared to White youth. In phase 1 of this project, we worked directly with Latinx youth, their families, and diabetes care team members in California to develop DREAM, Device use Reimagined through Education And Mentorship, a virtual peer group (VPG) intervention that will encourage and support the use of diabetes devices in Latinx adolescents with T1D. The goals for phase 2 (intervention) of this project are to evaluate the feasibility and acceptability of the stakeholder-informed VPG intervention, and evaluate clinical and person-centered outcomes.

Official Title

Optimizing Diabetes Technology Use for Latinx Youth Through DREAM (Device Use Reimagined Through Education And Mentorship) Virtual Peer Groups [Study-wide] - DREAM Intervention

Quick Facts

Study Start:2024-10-11
Study Completion:2026-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06546930

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Adolescents 13-17 years old and their caregivers
  2. * Adolescent must have T1D of any duration, and be receiving diabetes care at UCSF, CHLA or UC Davis
  3. * Self-identify as Latina/o/x or other variations such as Hispanic
  4. * Preferred language of English or Spanish
  1. * Participants who have a medical, developmental, or psychiatric condition that would make peer group participation difficult
  2. * Adolescents who are planning to transfer care to a different medical center within the next year, which would prevent assessment of longitudinal outcomes

Contacts and Locations

Study Contact

Marysol Gonzales Granados, BA
CONTACT
628-224-8436
Marysol.Gonzalesgranados@ucsf.edu
Jenise C Wong, MD, PhD
CONTACT
415-476-3316
Jenise.Wong@ucsf.edu

Principal Investigator

Jenise C Wong, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, Davis
Davis, California, 95616
United States
Children's Hospital Los Angeles
Los Angeles, California, 90027
United States
University of California, San Francisco
San Francisco, California, 94158
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Jenise C Wong, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-11
Study Completion Date2026-05-31

Study Record Updates

Study Start Date2024-10-11
Study Completion Date2026-05-31

Terms related to this study

Keywords Provided by Researchers

  • T1D
  • Diabetes
  • Diabetes Mellitus
  • Type 1

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 1